BioSpace News Archive

TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) is pleased to announce that it has entered into a letter of intent, dated February 11, 2020 (the “LOI”) with Psilocin Pharma Corp. (“Psilocin”), an arm’s length party incorporated pursuant to the laws of the Province of Ontario. Pursuant to the terms of the LOI, Revive will acquire all of the issued and outstanding securities of Psilocin (the “Proposed Acquisition”) for an aggregate purchase price o

All consolidated entities revenues grew plus compared to prior year YONGIN, South Korea , Feb. 12, 2020 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2019 . Key Figures (1 ) Full Year 2019 (2 )

Feb. 12, 2020 14:00 UTC Healthcare Technology Company Becomes Organization’s Provider of Enterprise Solutions for Pharmacy Benefits Administration BOSTON--( BUSINESS WIRE )-- RxSense ®, the healthcare technology company, today announced a partnership with the Health Plan Alliance , a nationwide network of health plans and systems, to join its group purchasing organization as the provider of enterprise solutions for pharmacy benefits administration. RxSense will offer the

Feb. 12, 2020 14:00 UTC LAGUNA HILLS, Calif.--( BUSINESS WIRE )-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that it has received the Certificates of Analysis and the records from both batches of its clinical trial product manufactured by Austrianova Singapore (Austrianova). As previously reported, both batc

Feb. 12, 2020 14:00 UTC Advancement Aimed at Bridging Gap between Automation and Autonomy CAMBRIDGE, Mass.--( BUSINESS WIRE )-- For the National Center for Advancing Translational Sciences ( NCATS ), it’s all about delivering new treatments and cures for diseases faster. “If you ask a patient when they want their cure, they’ll say yesterday,” said Sam Michael, NCATS chief information officer. “Generating a new therapeutic can take 10 to 15 years and billions of dollars

Feb. 12, 2020 14:00 UTC SALT LAKE CITY--( BUSINESS WIRE )-- PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the pricing of an underwritten public offering of approximately 10,638,298 shares of its common stock and warrants to purchase up to 10,638,298 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase one share of common stoc

WBC Group, a leading national health and wellness distributor, announced today that it is changing its name to Boxout.

Intellectual and developmental disabilities (IDD) service companies, required to survey individuals and their guardians annually, historically mailed paper-based surveys that yielded few responses

- 9th Annual Leerink Partners Global Healthcare Conference on February 26 in New York City - Cowen and Company 40th Annual Health Care Conference on March 3 in Boston [12-February-2020] SAN RAFAEL, Calif. , Feb. 12, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the 9th Annual Leerink Part

Glen Rock, N.J., Feb. 12, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), a leader in the development of medicines for respiratory disorders and central nervous system (“CNS”) indications, with a focus on obstructive sleep apnea, attention deficit hyperactivity disorder (“ADHD”), spinal cord injury and other neurological conditions, today provides a progress and status report to its stockholders, stakeholders, strategic partners as well as other interested parties. D